Literature DB >> 19610534

Microalbuminuria prevalence study in hypertensive patients with type 2 diabetes in Pakistan.

Muhammad Yakoob Ahmadani1, Asher Fawwad, Abdul Basit, Zafar Iqbal Hydrie.   

Abstract

BACKGROUND: Microalbuminuria is a renal marker of general vascular endothelial damage and early atherosclerosis with adverse prognostic implications. It is associated with diabetes, insulin resistance, central adiposity and hypertension.
OBJECTIVE: The Microalbuminuria Prevalence Study (MAPS) aimed to assess the prevalence of microalbuminuria in consecutively-screened hypertensive adult patients with type 2 diabetes mellitus in 103 centres of ten Asian countries.
DESIGN: Cross-sectional clinic-based epidemiological study.
METHODS: This is the sub-analysis of data collected from patients attending the OPD of Baqai Institute of Diabetology and Endocrinology in Pakistan. Patients attended one study visit with no follow-up. Patients with bacteriuria and haematuria were excluded.
RESULTS: A total of 99 subjects were studied out of which 56.3% were females. Mean age was 49.9 +/- 10.8 years. The prevalence of macroalbuminuria and microalbuminuria was 9.09% and 24.2% respectively.
CONCLUSION: In Pakistan the prevalence of diabetic kidney disease was high in diabetic hypertensive subjects which is alarming and indicates an impending pandemic of diabetic renal and cardiovascular disease in the region.

Entities:  

Mesh:

Year:  2008        PMID: 19610534

Source DB:  PubMed          Journal:  J Ayub Med Coll Abbottabad        ISSN: 1025-9589


  2 in total

1.  Identifying the determinants of microalbuminuria in obese patients in primary care units: the effects of blood pressure, random plasma glucose and other risk factors.

Authors:  E Pehlivan; G Ozen; H Taskapan; G Gunes; I Sahin; C Colak
Journal:  J Endocrinol Invest       Date:  2015-06-21       Impact factor: 4.256

2.  Correlation between Microalbuminuria and Hypertension in Type 2 Diabetic Patients.

Authors:  Alia Ali; Azeem Taj; Muhammad Joher Amin; Farrukh Iqbal; Zafar Iqbal
Journal:  Pak J Med Sci       Date:  2014-05       Impact factor: 1.088

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.